Related Experiment Video
Updated: Jun 6, 2025
00:04
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.6K
Real-world data: bridging the gap between clinical trials and practice.
Brooke E Wilson1,2,3, Christopher M Booth1,2
1Department of Oncology, Queen's University, Kingston, Ontario, Canada.
Eclinicalmedicine
|November 26, 2024
Summary
Real-world data (RWD) can complement randomized controlled trials (RCTs), but direct replication of efficacy is challenging due to inherent data differences. Novel trial designs may help bridge this gap.
Area of Science:
- Health Informatics
- Clinical Trials
- Real-World Evidence
Background:
- Randomized controlled trials (RCTs) provide high-quality drug efficacy evidence but can be impractical for rare diseases.
- Observational studies using real-world data (RWD) often fail to replicate RCT findings.
- Inherent differences exist between clinical trial data and real-world observational data.
Purpose of the Study:
- To explore the challenges associated with real-world data (RWD).
- To discuss considerations for clinicians, patients, and regulators when encountering conflicting efficacy and effectiveness data.
- To examine novel trial designs that could integrate RCTs and RWD.
Main Methods:
- This viewpoint discusses the challenges and potential of RWD in relation to RCTs.
- It analyzes the discordance between clinical trial efficacy and real-world effectiveness.
- Novel clinical trial designs are explored as a potential solution.
Main Results:
- Direct replication of clinical trial results using RWD has proven unsuccessful.
- RWD possesses independent value as a complementary evidence source to RCTs.
- Significant challenges exist in reconciling efficacy from RCTs with effectiveness from RWD.
Conclusions:
- RWD presents unique challenges and limitations when compared to RCTs.
- Clinicians, patients, and regulators must carefully consider discrepancies between trial efficacy and real-world effectiveness.
- Innovative trial designs are needed to effectively bridge the gap between traditional RCTs and RWD.
Related Concept Videos
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:11Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:16Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K